Cytotoxicity Potential of Endophytic Fungi Extracts from Terminalia catappa against Human Cervical Cancer Cells

Endophytic fungi are potential sources of novel bioactive metabolites from a natural product drug discovery perspective. This study reports the bioactivity-directed fractionation of the secondary metabolites of the ethyl acetate extract of a fermentation culture of endophytic fungi from Terminalia c...

Full description

Saved in:
Bibliographic Details
Main Authors: Michèle Stella Majoumouo, Marius Belmondo Tincho, Rufin Marie Kouipou Toghueo, Thureyah Morris, Donavon Charles Hiss, Fabrice Fekam Boyom, Chitra Mandal
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Toxicology
Online Access:http://dx.doi.org/10.1155/2020/8871152
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566150590889984
author Michèle Stella Majoumouo
Marius Belmondo Tincho
Rufin Marie Kouipou Toghueo
Thureyah Morris
Donavon Charles Hiss
Fabrice Fekam Boyom
Chitra Mandal
author_facet Michèle Stella Majoumouo
Marius Belmondo Tincho
Rufin Marie Kouipou Toghueo
Thureyah Morris
Donavon Charles Hiss
Fabrice Fekam Boyom
Chitra Mandal
author_sort Michèle Stella Majoumouo
collection DOAJ
description Endophytic fungi are potential sources of novel bioactive metabolites from a natural product drug discovery perspective. This study reports the bioactivity-directed fractionation of the secondary metabolites of the ethyl acetate extract of a fermentation culture of endophytic fungi from Terminalia catappa which were then evaluated for their cytotoxicity against human cervical cancer (HeLa) cells and human foreskin fibroblast (HFF) cells. Furthermore, apoptosis was determined using the Annexin V/propidium iodide (PI) flow cytometry assay. Endophyte extracts N2, N7, N8, N97, N169, and N233 were obtained from Trichoderma sp, Phoma sp, Phomopsis phyllanticola, Fusarium oxyporum, Collectotrichum sp, and Cryptococcus flavescens, respectively. The N97 extract was most active with a 50% inhibitory concentration (IC50) of 33.35 µg/ml. A 50% cytotoxic concentration (CC50) of 268.4 µg/ml was obtained with HFF cells and the selectivity index (SI) was 8.01. The percentages of cell populations were increased at late apoptosis (Annexin+/PI+), with the percentages of 27.4 ± 0.3 and 19.2 ± 0.01 obtained, respectively, for 50 µg/ml and 80 µg/ml of the N97 extract and 2.1 ± 0.1 obtained for the control in late apoptosis (Annexin V+/PI+) . Moreover, a higher reduction in the percentage of viable cells was observed in the HeLa control cells (93.6 ± 0.3), but the percentages of viable HeLa cells were 37 ± 0.05 and 45 ± 0.1, respectively, for the 50 µg/ml and 80 µg/ml treatments with the N97 extract. Also, the percentages of 34.7 ± 0.1 and 33.9 ± 0.4 were, respectively, obtained for 50 µg/ml and 80 µg/ml compared to the control with 4.6 ± 0.2, in early apoptosis (Annexin V+/PI-). These findings highlight the anticancer potential of the N97 extract of endophytic fungi from Terminalia catappa, which is mediated through apoptosis and presumably also attenuation of chemoresistance.
format Article
id doaj-art-9db971f11e8f4148abd907d77a648436
institution Kabale University
issn 1687-8191
1687-8205
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Journal of Toxicology
spelling doaj-art-9db971f11e8f4148abd907d77a6484362025-02-03T01:05:02ZengWileyJournal of Toxicology1687-81911687-82052020-01-01202010.1155/2020/88711528871152Cytotoxicity Potential of Endophytic Fungi Extracts from Terminalia catappa against Human Cervical Cancer CellsMichèle Stella Majoumouo0Marius Belmondo Tincho1Rufin Marie Kouipou Toghueo2Thureyah Morris3Donavon Charles Hiss4Fabrice Fekam Boyom5Chitra Mandal6Antimicrobial Agents Unit, Laboratory for Phytobiochemistry and Medicinal Plants Studies, Department of Biochemistry, P.O. Box 812, University of Yaoundé 1, Yaounde, CameroonDepartment of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Private Bag X17, Bellville 7535, South AfricaAntimicrobial Agents Unit, Laboratory for Phytobiochemistry and Medicinal Plants Studies, Department of Biochemistry, P.O. Box 812, University of Yaoundé 1, Yaounde, CameroonFood Toxicology Laboratory, Department of Medical Bioscience, Faculty of Natural Sciences, University of the Western Cape, Private Bag X17, Bellville 7535, South AfricaMolecular Oncology Laboratory, Department of Medical Bioscience, Faculty of Natural Sciences, University of the Western Cape, Private Bag X17, Bellville 7535, South AfricaAntimicrobial Agents Unit, Laboratory for Phytobiochemistry and Medicinal Plants Studies, Department of Biochemistry, P.O. Box 812, University of Yaoundé 1, Yaounde, CameroonCancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology, 4, Raja S.C. Mallick Road, Kolkata 700032, West Bengal, IndiaEndophytic fungi are potential sources of novel bioactive metabolites from a natural product drug discovery perspective. This study reports the bioactivity-directed fractionation of the secondary metabolites of the ethyl acetate extract of a fermentation culture of endophytic fungi from Terminalia catappa which were then evaluated for their cytotoxicity against human cervical cancer (HeLa) cells and human foreskin fibroblast (HFF) cells. Furthermore, apoptosis was determined using the Annexin V/propidium iodide (PI) flow cytometry assay. Endophyte extracts N2, N7, N8, N97, N169, and N233 were obtained from Trichoderma sp, Phoma sp, Phomopsis phyllanticola, Fusarium oxyporum, Collectotrichum sp, and Cryptococcus flavescens, respectively. The N97 extract was most active with a 50% inhibitory concentration (IC50) of 33.35 µg/ml. A 50% cytotoxic concentration (CC50) of 268.4 µg/ml was obtained with HFF cells and the selectivity index (SI) was 8.01. The percentages of cell populations were increased at late apoptosis (Annexin+/PI+), with the percentages of 27.4 ± 0.3 and 19.2 ± 0.01 obtained, respectively, for 50 µg/ml and 80 µg/ml of the N97 extract and 2.1 ± 0.1 obtained for the control in late apoptosis (Annexin V+/PI+) . Moreover, a higher reduction in the percentage of viable cells was observed in the HeLa control cells (93.6 ± 0.3), but the percentages of viable HeLa cells were 37 ± 0.05 and 45 ± 0.1, respectively, for the 50 µg/ml and 80 µg/ml treatments with the N97 extract. Also, the percentages of 34.7 ± 0.1 and 33.9 ± 0.4 were, respectively, obtained for 50 µg/ml and 80 µg/ml compared to the control with 4.6 ± 0.2, in early apoptosis (Annexin V+/PI-). These findings highlight the anticancer potential of the N97 extract of endophytic fungi from Terminalia catappa, which is mediated through apoptosis and presumably also attenuation of chemoresistance.http://dx.doi.org/10.1155/2020/8871152
spellingShingle Michèle Stella Majoumouo
Marius Belmondo Tincho
Rufin Marie Kouipou Toghueo
Thureyah Morris
Donavon Charles Hiss
Fabrice Fekam Boyom
Chitra Mandal
Cytotoxicity Potential of Endophytic Fungi Extracts from Terminalia catappa against Human Cervical Cancer Cells
Journal of Toxicology
title Cytotoxicity Potential of Endophytic Fungi Extracts from Terminalia catappa against Human Cervical Cancer Cells
title_full Cytotoxicity Potential of Endophytic Fungi Extracts from Terminalia catappa against Human Cervical Cancer Cells
title_fullStr Cytotoxicity Potential of Endophytic Fungi Extracts from Terminalia catappa against Human Cervical Cancer Cells
title_full_unstemmed Cytotoxicity Potential of Endophytic Fungi Extracts from Terminalia catappa against Human Cervical Cancer Cells
title_short Cytotoxicity Potential of Endophytic Fungi Extracts from Terminalia catappa against Human Cervical Cancer Cells
title_sort cytotoxicity potential of endophytic fungi extracts from terminalia catappa against human cervical cancer cells
url http://dx.doi.org/10.1155/2020/8871152
work_keys_str_mv AT michelestellamajoumouo cytotoxicitypotentialofendophyticfungiextractsfromterminaliacatappaagainsthumancervicalcancercells
AT mariusbelmondotincho cytotoxicitypotentialofendophyticfungiextractsfromterminaliacatappaagainsthumancervicalcancercells
AT rufinmariekouipoutoghueo cytotoxicitypotentialofendophyticfungiextractsfromterminaliacatappaagainsthumancervicalcancercells
AT thureyahmorris cytotoxicitypotentialofendophyticfungiextractsfromterminaliacatappaagainsthumancervicalcancercells
AT donavoncharleshiss cytotoxicitypotentialofendophyticfungiextractsfromterminaliacatappaagainsthumancervicalcancercells
AT fabricefekamboyom cytotoxicitypotentialofendophyticfungiextractsfromterminaliacatappaagainsthumancervicalcancercells
AT chitramandal cytotoxicitypotentialofendophyticfungiextractsfromterminaliacatappaagainsthumancervicalcancercells